# LYVA Labs

> LYVA Labs is a VC fund in Liverpool backing Medical and Health Care. See 13 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Liverpool, United Kingdom
- Total investments: 13
- Last investment: Mar 2026
- Lead investor: 38%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/lyvalabs
- X (Twitter): https://twitter.com/LyvaLabs
- Website: https://lyvalabs.com

LYVA Labs is a VC fund in Liverpool focused on Medical and Health Care. LYVA Labs provides early-stage innovation investment and support for ideas and technologies being developed.

## Contacts

5 contacts available for LYVA Labs. Shizune tracks 4 team members at LYVA Labs. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lyva-labs?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 15% |
| Health Care | 2 | 15% |
| Medical Device | 2 | 15% |
| Solar | 1 | 8% |
| Internet | 1 | 8% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 69% |
| Pre-Seed | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 6 | 46% |
| The Netherlands | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Lorna Green | Chief Executive Officer | 3 | https://shizune.co/investors/profile/lorna-green-7550 |
| Vijay Curthan | Portfolio Investment Director | 5 | https://shizune.co/investors/profile/vijay-curthan |
| Akshay Bhatnagar | VC Investment Director | 6 | https://shizune.co/investors/profile/akshay-bhatnagar-ca31 |
| Elaine Loukes | Portfolio Investment Director | 8 | https://shizune.co/investors/profile/elaine-loukes |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Spotlight Pathology | Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers. | $1.9M | Seed | Mar 11, 2026 |  |
| Spotlight Pathology | Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers. | $1.9M | Seed | Mar 11, 2026 |  |
| Respiosa | A simple, min-imally invasive surgically implanted solution to provide optimal therapy for tongue-based OSA. Respiosa prevents the tongue from collapsing into the airway when patients sleep on their backs. Designed and tested by world-class developers with ENT surgeons, the novel Respiosa implant system promises to deliver effective, durable andadjustable therapy. | $664.7K | Seed | Dec 03, 2025 |  |
| SenseAI | SenseAIsoftware dramatically speeds up image acquisition while reducing sample damage from high-energy electron beams, offering up to 100x improvements in efficiency without loss of image integrity. |  | Seed | Sep 08, 2025 |  |
| Spotlight Pathology | Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers. | $570K | Seed | Apr 29, 2025 |  |
| CCI Photonics | CCI Photonics specialises in medical instruments and supplies, as well as conducting biotechnology research and development. | $560.5K | Seed | Jan 29, 2025 |  |
| Atomik AM | Innovative chemistry, solutions-based engineering, and a solution-focused philosophy enable us to meet the goals and commercial requirements of manufacturers. | $155.6K | Seed | Jan 27, 2025 |  |
| Cubode | Cubode is the easiest web platform to learn how to create software products by building graphically, without memorising coding syntax. Cubode is a tool for people to create without boundaries, to enable innovation to anyone with an idea regardless of who they are, their previous background or where they are. |  | Seed | Nov 07, 2024 |  |
| Spotlight Pathology | Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers. | $162.6K | Pre-Seed | Jul 17, 2024 |  |
| Spotlight Pathology | Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers. | $162.6K | Pre-Seed | Jul 17, 2024 |  |

10 of 13 investments shown.

## Co-investors
- [AXM Venture Capital](https://shizune.co/investors/profile/axm-venture-capital) — VC Fund, 3 deals together
- [Baltic Ventures](https://shizune.co/investors/profile/baltic-ventures) — VC Fund, 3 deals together
- [Deepbridge Capital](https://shizune.co/investors/profile/deepbridge-capital) — VC Fund, 3 deals together
- [EHE Ventures](https://shizune.co/investors/profile/ehe-ventures) — VC Fund, 3 deals together
- [UK Innovation & Science Seed Fund](https://shizune.co/investors/profile/rainbow-seed-fund) — VC Fund, 2 deals together
- [River Capital](https://shizune.co/investors/profile/river-capital-3b1d) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does LYVA Labs invest in?

LYVA Labs invests primarily in Medical, Health Care and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 13 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact LYVA Labs?

Public channels for LYVA Labs include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LYVA Labs?

The team at LYVA Labs includes Lorna Green (Chief Executive Officer), Vijay Curthan (Portfolio Investment Director) and Akshay Bhatnagar (VC Investment Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co